FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890757469> ?p ?o ?g. }

• W2890757469 endingPage "275" @default.
• W2890757469 startingPage "268" @default.
• W2890757469 abstract "Background: Biologic agents inhibiting the tumor necrosis factor α pathway (TNFα-Is) are used to treat systemic inflammatory diseases. The best management of these agents after renal transplantation is unknown. Objective: Evaluate peritransplant use of TNFα-Is and associated outcomes. Methods: Retrospective, single-center study of adult renal-transplant-recipients (RTRs) transplanted between 1/1/1998-12/31/2017, who received TNFα-Is for inflammatory disease prior to transplant. Qualifying patients were divided into 2 cohorts: patients who resumed TNFα-Is after transplant and those who did not. Outcomes were evaluated. Results: A total of 5256 renal transplants occurred in the study window; 14 patients met inclusion criteria. Primary indication for TNFα-I was Crohn’s-disease (CD; 57.1%). Infliximab was utilized most frequently (50%). Seven RTRs resumed TNFα-I posttransplant; mean time to resumption of 10.6±4.35 months (median=6 months), 85.7% for CD. Immunosuppression was modified in 2 patients (28.6%) in response to restarting TNFα-I therapy. Seven RTRs did not resume TNFα-Is following transplant; the majority of these had rheumatic diseases. There was no significant difference in time to first bacterial or fungal infection, rejection, or patient survival between the 2 groups. Last measured estimated glomerular-filtration-rate was similar between groups (TNFα-I: 41 ± 14.2 vs 48.6 ± 8.6, P = 0.25). No patient had cytomegalovirus infection; however, 42.8% of each cohort had documented BK virus infection. Malignancy occurred more frequently in the cohort that resumed TNFα-Is (42.8% vs 14.3%, P = 0.24); however, this was not statistically significant. Conclusion and Relevance: TNFα-I therapy prior to renal-transplant is relatively uncommon. The decision to continue therapy after transplant must balance risks of infection and malignancy against inflammatory disease recurrence. A multidisciplinary treatment approach is necessary as use of TNFα-I affects immunosuppressive management and appears to affect transplant outcomes. Future studies are needed to further clarify the role of TNFα-I therapy use in RTRs with inflammatory disorders focusing on its correlation with both BK and malignancy." @default.
• W2890757469 created "2018-09-27" @default.
• W2890757469 creator A5002731748 @default.
• W2890757469 creator A5004260684 @default.
• W2890757469 creator A5025694734 @default.
• W2890757469 creator A5026296778 @default.
• W2890757469 creator A5037545578 @default.
• W2890757469 creator A5046705698 @default.
• W2890757469 date "2018-09-20" @default.
• W2890757469 modified "2023-09-24" @default.
• W2890757469 title "Management of Tumor Necrosis Factor α Inhibitor Therapy After Renal Transplantation: A Comparative Analysis and Associated Outcomes" @default.
• W2890757469 cites W1924926011 @default.
• W2890757469 cites W2051955503 @default.
• W2890757469 cites W2073342144 @default.
• W2890757469 cites W2073626117 @default.
• W2890757469 cites W2088533604 @default.
• W2890757469 cites W2154997623 @default.
• W2890757469 cites W2160232557 @default.
• W2890757469 cites W2167108511 @default.
• W2890757469 cites W2169711260 @default.
• W2890757469 cites W2473041787 @default.
• W2890757469 cites W2510966451 @default.
• W2890757469 cites W2530388185 @default.
• W2890757469 cites W2618144944 @default.
• W2890757469 doi "https://doi.org/10.1177/1060028018802814" @default.
• W2890757469 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30234366" @default.
• W2890757469 hasPublicationYear "2018" @default.
• W2890757469 type Work @default.
• W2890757469 sameAs 2890757469 @default.
• W2890757469 citedByCount "10" @default.
• W2890757469 countsByYear W28907574692021 @default.
• W2890757469 countsByYear W28907574692022 @default.
• W2890757469 countsByYear W28907574692023 @default.
• W2890757469 crossrefType "journal-article" @default.
• W2890757469 hasAuthorship W2890757469A5002731748 @default.
• W2890757469 hasAuthorship W2890757469A5004260684 @default.
• W2890757469 hasAuthorship W2890757469A5025694734 @default.
• W2890757469 hasAuthorship W2890757469A5026296778 @default.
• W2890757469 hasAuthorship W2890757469A5037545578 @default.
• W2890757469 hasAuthorship W2890757469A5046705698 @default.
• W2890757469 hasConcept C126322002 @default.
• W2890757469 hasConcept C141071460 @default.
• W2890757469 hasConcept C159641895 @default.
• W2890757469 hasConcept C167135981 @default.
• W2890757469 hasConcept C17991360 @default.
• W2890757469 hasConcept C203014093 @default.
• W2890757469 hasConcept C2777138892 @default.
• W2890757469 hasConcept C2779399171 @default.
• W2890757469 hasConcept C2780252810 @default.
• W2890757469 hasConcept C2911091166 @default.
• W2890757469 hasConcept C71924100 @default.
• W2890757469 hasConcept C72563966 @default.
• W2890757469 hasConcept C90924648 @default.
• W2890757469 hasConceptScore W2890757469C126322002 @default.
• W2890757469 hasConceptScore W2890757469C141071460 @default.
• W2890757469 hasConceptScore W2890757469C159641895 @default.
• W2890757469 hasConceptScore W2890757469C167135981 @default.
• W2890757469 hasConceptScore W2890757469C17991360 @default.
• W2890757469 hasConceptScore W2890757469C203014093 @default.
• W2890757469 hasConceptScore W2890757469C2777138892 @default.
• W2890757469 hasConceptScore W2890757469C2779399171 @default.
• W2890757469 hasConceptScore W2890757469C2780252810 @default.
• W2890757469 hasConceptScore W2890757469C2911091166 @default.
• W2890757469 hasConceptScore W2890757469C71924100 @default.
• W2890757469 hasConceptScore W2890757469C72563966 @default.
• W2890757469 hasConceptScore W2890757469C90924648 @default.
• W2890757469 hasIssue "3" @default.
• W2890757469 hasLocation W28907574691 @default.
• W2890757469 hasLocation W28907574692 @default.
• W2890757469 hasOpenAccess W2890757469 @default.
• W2890757469 hasPrimaryLocation W28907574691 @default.
• W2890757469 hasRelatedWork W105963342 @default.
• W2890757469 hasRelatedWork W1793302197 @default.
• W2890757469 hasRelatedWork W1965554526 @default.
• W2890757469 hasRelatedWork W1984976117 @default.
• W2890757469 hasRelatedWork W2018191311 @default.
• W2890757469 hasRelatedWork W2065277904 @default.
• W2890757469 hasRelatedWork W2065404554 @default.
• W2890757469 hasRelatedWork W3016712764 @default.
• W2890757469 hasRelatedWork W3032898362 @default.
• W2890757469 hasRelatedWork W4238624075 @default.
• W2890757469 hasVolume "53" @default.
• W2890757469 isParatext "false" @default.
• W2890757469 isRetracted "false" @default.
• W2890757469 magId "2890757469" @default.
• W2890757469 workType "article" @default.